Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly
暂无分享,去创建一个
S. Shakib | S. Frey | P. Richmond | T. Tantawichien | P. Chanthavanich | N. Kanesa-thasan | M. Hohenboken | B. Verma | P. Jaehnig | Timothy Smith | C. Kittel | Z. Mojares